Peer Exchange - Page 2

Our Peer Exchange™ program provides a multi-stakeholder perspective on important issues that providers, pharmacists, payers, and patients grapple with as they step into the world of biosimilars.
The panelists discuss whether confirmatory clinical studies will always be needed for biosimilars to be approved in the United States.
The panel discusses how interchangeability may be misunderstood or misrepresented.
The experts discuss the potential for immunogenicity with biosimilar medicines.
Carlos Sattler, MD, discusses how the most sensitive population is identified for phase 3 studies of biosimilars.
The experts consider how comfortable providers are with the extrapolation of indications based on clinical studies in one disease state.
The experts consider clinicians’ awareness of manufacturing changes for reference biologics and their relationship to biosimilarity.
 
The panelists discuss how much education providers have on the concepts of manufacturing changes and comparability and how those concepts relate to biosimilarity. 
 
Carlos Sattler, MD, analyzes how the FDA has addressed biosimilar education to date.
 
The panelists discuss how the United States and the European Union differ in terms of biosimilar education.
The experts discuss the kinds of education that providers need about biosimilars.
 

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities


Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.